PTGS2
Prostaglandin G/H synthase 2
Also known as: COX2, PGH2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35354
- Gene
- PTGS2
- Ensembl
- ENSG00000073756
- Chromosome
- 1
- Canonical length
- 604 aa
- Protein class
- Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Prostaglandin-endoperoxide synthase (PTGS), also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. There are two isozymes of PTGS: a constitutive PTGS1 and an inducible PTGS2, which differ in their regulation of expression and tissue distribution. This gene encodes the inducible isozyme. It is regulated by specific stimulatory events, suggesting that it is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
604 residues, UniProt reviewed canonical sequence.
>P35354|PTGS2
1 MLARALLLCA VLALSHTANP CCSHPCQNRG VCMSVGFDQY KCDCTRTGFY GENCSTPEFL
61 TRIKLFLKPT PNTVHYILTH FKGFWNVVNN IPFLRNAIMS YVLTSRSHLI DSPPTYNADY
121 GYKSWEAFSN LSYYTRALPP VPDDCPTPLG VKGKKQLPDS NEIVEKLLLR RKFIPDPQGS
181 NMMFAFFAQH FTHQFFKTDH KRGPAFTNGL GHGVDLNHIY GETLARQRKL RLFKDGKMKY
241 QIIDGEMYPP TVKDTQAEMI YPPQVPEHLR FAVGQEVFGL VPGLMMYATI WLREHNRVCD
301 VLKQEHPEWG DEQLFQTSRL ILIGETIKIV IEDYVQHLSG YHFKLKFDPE LLFNKQFQYQ
361 NRIAAEFNTL YHWHPLLPDT FQIHDQKYNY QQFIYNNSIL LEHGITQFVE SFTRQIAGRV
421 AGGRNVPPAV QKVSQASIDQ SRQMKYQSFN EYRKRFMLKP YESFEELTGE KEMSAELEAL
481 YGDIDAVELY PALLVEKPRP DAIFGETMVE VGAPFSLKGL MGNVICSPAY WKPSTFGGEV
541 GFQIINTASI QSLICNNVKG CPFTSFSVPD PELIKTVTIN ASSSRSGLDD INPTVLLKER
601 STELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTGS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 151 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 151 nTPM
- seminal vesicle: 120 nTPM
- bone marrow: 110 nTPM
- cervix: 58 nTPM
- lung: 35 nTPM
- gallbladder: 30 nTPM
Single-cell type
- neutrophils: 1,509 nCPM
- epididymal basal cells: 666 nCPM
- monocytes: 659 nCPM
- urothelial cells: 451 nCPM
- mast cells: 391 nCPM
- ocular epithelial cells: 382 nCPM
Immune cell
- neutrophil: 12 nTPM
- intermediate monocyte: 0.7 nTPM
- myeloid DC: 0.4 nTPM
- non-classical monocyte: 0.4 nTPM
- classical monocyte: 0.3 nTPM
- eosinophil: 0.2 nTPM
Brain region
- cerebral cortex: 6.4 nTPM
- choroid plexus: 3.9 nTPM
- white matter: 3.6 nTPM
- medulla oblongata: 2.2 nTPM
- spinal cord: 2.2 nTPM
- thalamus: 2.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTGS2.
Disease | ImmuneIEDB
Conditions an epitope on PTGS2 was assayed in.
- colorectal cancer T cell
ReferencesPubMed · IEDB
Publications for PTGS2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- IgA2 ACPA Drives a Hyper-Inflammatory Phenotype in Macrophages via ATP Synthase and COX2.
2025 · Eur J Immunol · RCR 2 · 5 citations - Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.
2022 · Leukemia · RCR 1.1 · 14 citations
Reference: T cellIEDB
1 publication
- Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention.
2021 · Front Immunol · RCR 1.8 · 31 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.48
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brown fat cell differentiation
- cellular response to fluid shear stress
- cellular response to hypoxia
- cyclooxygenase pathway
- decidualization
- embryo implantation
- lipoxygenase pathway
- long-chain fatty acid biosynthetic process
- negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
- positive regulation of brown fat cell differentiation
- positive regulation of cell migration involved in sprouting angiogenesis
- positive regulation of fever generation
- positive regulation of fibroblast growth factor production
- positive regulation of nitric oxide biosynthetic process
- positive regulation of platelet-derived growth factor production
- positive regulation of prostaglandin biosynthetic process
- positive regulation of transforming growth factor beta production
- positive regulation of vascular endothelial growth factor production
- prostaglandin biosynthetic process
- prostaglandin secretion
- regulation of blood pressure
- regulation of cell population proliferation
- regulation of inflammatory response
- regulation of neuroinflammatory response
- response to nematode
- response to oxidative stress
- response to selenium ion
- cellular response to non-ionic osmotic stress
Molecular functions
- enzyme binding
- heme binding
- metal ion binding
- oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
- oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
- peroxidase activity
- prostaglandin-endoperoxide synthase activity
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTGS2 as an antibody target. Whether an autoantibody or antibody against PTGS2 could matter depends on whether native PTGS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTGS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTGS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...